Real-time glucose monitoring a sweet-treat for type-1 and type-2 diabetes

Publicly released:
International
Image by Tesa Robbins from Pixabay
Image by Tesa Robbins from Pixabay

Continuous real-time monitoring of glucose levels could provide better glycemic control and lower rates of hypoglycemia for sufferers of type-1 and type-2 diabetes, according to international research. The study looked at 41,753 patients with insulin-treated diabetes who were self-monitoring their blood glucose levels. They found that using a continuous glucose monitoring (CGM) system, which takes blood glucose readings every five minutes with sensors implanted under the skin, resulted in significantly lower blood sugar levels, and lower rates of emergency department visits or hospitalisations for low blood sugar. However, the study found no difference in the rate of emergency department visits or hospitalisations for high blood sugar levels.

Media release

From: JAMA

What The Study Did: Researchers investigated the effect of real-time continuous glucose monitoring on glycemic control among patients with insulin-treated diabetes.

Journal/
conference:
JAMA Original Investigation
Research:Paper
Organisation/s: Kaiser Permanente, USA
Funder: This research was supported by an independent investigator award from Dexcom and funding from grants R01 DK103721 and P30 DK092924 from the NIDDK.
Media Contact/s
Contact details are only visible to registered journalists.